Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study
2008

Faecal tumour M2 PK for CRC precursor detection

Sample size: 1082 publication Evidence: low

Author Information

Author(s): Haug U, Hundt S, Brenner H

Primary Institution: German Cancer Research Center

Hypothesis

The study aims to determine the performance characteristics of the tumour M2 PK test with respect to colorectal adenomas in a large screening population.

Conclusion

The tumour M2 PK test has only very limited potential to distinguish between people bearing precursors to colorectal cancer and those with no findings at colonoscopy.

Supporting Evidence

  • The median tumour M2 PK level in the study population was 1.3 U ml−1.
  • Sensitivity for advanced adenomas was 22% and for other adenomas was 23%.
  • Specificity was about 82% regardless of the inclusion of hyperplastic polyps.

Takeaway

This study looked at a test that checks stool for a substance related to cancer, but it found that the test isn't very good at spotting early signs of colorectal cancer.

Methodology

Participants provided stool samples before colonoscopy, which were analyzed for tumour M2 PK levels using a sandwich ELISA.

Limitations

The study may be limited by the diagnostic accuracy of colonoscopy and the involvement of multiple gastroenterologists.

Participant Demographics

Mean age was 63 years, with 50% females.

Statistical Information

P-Value

P=0.002 for age group differences in tumour M2 PK levels.

Confidence Interval

95% CI for sensitivity was 14–31% for advanced adenomas and 17–29% for other adenomas.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604427

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication